Prior studies, largely among middle-aged adults, have reported that taking aspirin reduces the risk of cancer after 10 years, particularly for colorectal cancer. However, new Monash University research has found that for ...
Jan 29, 2026
0
0
A new in vivo pharmacokinetic recall study involving 114 participants in the Estonian Biobank has provided the first clinical confirmation that previously uncharacterized genetic variants in the drug-metabolizing enzymes ...
Jan 29, 2026
0
0
Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in patients with aggressive inflammatory breast cancer. The study uncovers a novel role for soluble ...
Jan 29, 2026
0
0
Mayo Clinic researchers have developed a promising gene-editing therapy that directly corrects a genetic mutation responsible for autosomal dominant polycystic kidney disease (ADPKD), the most common inherited kidney disorder.
Jan 29, 2026
0
0
A major international study has assessed key bacterial targets that could form the basis of a new maternal vaccine to protect newborns from life-threatening infections. The University of Strathclyde contributed analytical ...
Jan 29, 2026
0
0
An association between oral microbiota and cognitive performance in schizophrenia has been reported by researchers at Science Tokyo. By analyzing saliva samples and cognitive test scores from patients with schizophrenia and ...
Jan 29, 2026
0
0
Researchers from the University of Twente, MST and Politecnico di Milano conducted a pilot study to explore whether a GPT-controlled social robot can support patients with medical information in a hospital setting. The first ...
Jan 29, 2026
0
0
One in three people in Norway (32.5%) who have started hormone treatment, and half (49.5%) of those who have undergone gender affirming surgery, have obtained treatment entirely through private funding. That is the findings ...
Jan 29, 2026
0
0
Nearly half of American adults—some 126 million people—will be obese within 10 years, a new study projects.
Jan 29, 2026
0
0
New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and aggressive skin cancer, with immunotherapy before surgery can dramatically shrink or even eliminate ...
Jan 29, 2026
0
0
